Snap-on Inc·4

Feb 19, 5:59 PM ET

Pagliari Aldo John 4

4 · Snap-on Inc · Filed Feb 19, 2026

Research Summary

AI-generated summary of this filing

Updated

Snap‑on (SNA) CFO Aldo Pagliari Exercises Options, Sells Shares

What Happened
Pagliari Aldo John, Senior VP — Finance & Chief Financial Officer of Snap‑on Inc., exercised 10,000 stock options on February 19, 2026 at an exercise price of $168.70 (cost ≈ $1,687,000) and sold a total of 7,043 shares in open‑market transactions the same day for aggregate proceeds of approximately $2,690,785. The filing shows an additional derivative-related entry tied to the exercise; per the filing, a portion of the shares from the option exercise were sold to cover the exercise price and estimated tax liability under a Rule 10b5‑1 plan.

Key Details

  • Transaction date: 2026-02-19; Form filed 2026-02-19 (same day).
  • Option exercise: 10,000 shares acquired at $168.70 (≈ $1,687,000).
  • Open‑market sales (total 7,043 shares; total proceeds ≈ $2,690,785):
    • 1,778 shares at weighted avg $381.24 (prices ranged $380.48–$381.47). (F2)
    • 3,721 shares at weighted avg $381.93 (prices ranged $381.48–$382.46). (F3)
    • 984 shares at weighted avg $382.78 (prices ranged $382.50–$383.21). (F4)
    • 560 shares at weighted avg $384.14 (prices ranged $383.68–$384.29). (F5)
  • Notable footnotes: exercise plus partial sale to cover exercise price and taxes pursuant to a Rule 10b5‑1 plan adopted Nov 3, 2025 (F1, F7); option was fully vested (F6).
  • Shares owned after transaction: not disclosed in the provided filing details.
  • Filing timeliness: reported and filed on the same date as the transactions (no late filing indicated).

Context

  • This was an option exercise with contemporaneous share sales (a common “sell‑to‑cover” / cashless exercise pattern) rather than a pure open‑market buy; such transactions frequently reflect tax/transaction mechanics rather than a directional bet on the stock.
  • The sales were executed in multiple trades at slightly different prices (see ranges above); transactions were made under a Rule 10b5‑1 plan, which pre‑defines trades and can reduce concerns about trading on contemporaneous nonpublic information.
  • No indication in the provided data that the reporting person is a 10% owner; this is executive insider activity.

Insider Transaction Report

Form 4
Period: 2026-02-19
Pagliari Aldo John
Sr VP - Finance & CFO
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-19$168.70/sh+10,000$1,687,000124,226.056 total
  • Sale

    Common Stock

    [F1][F2]
    2026-02-19$381.24/sh1,778$677,838122,448.056 total
  • Sale

    Common Stock

    [F1][F3]
    2026-02-19$381.93/sh3,721$1,421,168118,727.056 total
  • Sale

    Common Stock

    [F1][F4]
    2026-02-19$382.78/sh984$376,659117,743.056 total
  • Sale

    Common Stock

    [F1][F5]
    2026-02-19$384.14/sh560$215,120117,183.056 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F1][F7][F6]
    2026-02-1910,00026,000 total
    Exercise: $168.70Exp: 2027-02-09Common Stock (10,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $161.18Exp: 2028-02-15Common Stock (26,052 underlying)
    26,052
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $155.92Exp: 2029-02-14Common Stock (23,500 underlying)
    23,500
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $155.34Exp: 2030-02-13Common Stock (23,500 underlying)
    23,500
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $189.89Exp: 2031-02-11Common Stock (14,986 underlying)
    14,986
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $211.67Exp: 2032-02-10Common Stock (11,252 underlying)
    11,252
  • Stock Option (Right to Buy)

    [F6]
    Exercise: $249.26Exp: 2033-02-09Common Stock (7,850 underlying)
    7,850
  • Stock Option (Right to Buy)

    [F8]
    Exercise: $269.00From: 2025-02-15Exp: 2034-02-15Common Stock (7,106 underlying)
    7,106
  • Stock Option (Right to Buy)

    [F8]
    Exercise: $339.73From: 2026-02-13Exp: 2035-02-13Common Stock (5,342 underlying)
    5,342
  • Stock Option (Right to Buy)

    [F8]
    Exercise: $378.55From: 2027-02-12Exp: 2036-02-12Common Stock (5,187 underlying)
    5,187
  • Restricted Stock Units

    [F9][F10]
    From: 2027-02-15Exp: 2027-02-15Common Stock (1,533 underlying)
    1,533
  • Restricted Stock Units

    [F9][F10]
    From: 2028-02-13Exp: 2028-02-13Common Stock (1,249 underlying)
    1,249
  • Restricted Stock Units

    [F9][F10]
    From: 2029-02-12Exp: 2029-02-12Common Stock (1,249 underlying)
    1,249
  • Performance Units

    [F9][F11]
    Common Stock (3,065 underlying)
    3,065
  • Performance Units

    [F9][F12]
    Common Stock (2,498 underlying)
    2,498
  • Performance Units

    [F9][F13]
    Common Stock (2,497 underlying)
    2,497
Footnotes (13)
  • [F1]The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
  • [F10]The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
  • [F11]If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F12]If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F13]If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F2]This transaction was executed in multiple trades at prices ranging from $380.48 to $381.47. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F3]This transaction was executed in multiple trades at prices ranging from $381.48 to $382.46. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F4]This transaction was executed in multiple trades at prices ranging from $382.50 to $383.21. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F5]This transaction was executed in multiple trades at prices ranging from $383.68 to $384.29. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
  • [F6]Option fully vested.
  • [F7]Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
  • [F8]Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
  • [F9]1 for 1.
Signature
/s/ Ryan S. Lovitz under Power of Attorney for Aldo J. Pagliari|2026-02-19

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): 2019 POWER OF ATTORNEY